News

UK-headquartered start-up Tenpoint Therapeutics has reeled in a commendable $70 million in first-round financing that will be used to develop its cell-based therapies for sight-robbing diseases.
CrimeWatch report from Hickory and Catawba County from Dec. 31, 2012 to Jan. 10, 2013 ...